| KKR |
Report |
Adjusted Net Income (EPS) |
IN-LINE |
pred ~$1.44 vs. cons $1.43 |
MEDIUM |
| KKR |
Report |
Fee Related Earnings / share |
BEAT |
pred ~$1.19 vs. cons ~$1.16 |
MEDIUM |
| KKR |
Report |
Total AUM |
IN-LINE |
pred ~$783B vs. cons $788B |
MEDIUM |
| KKR |
Guide |
FY2026 ANI/share framing (the '$7+' walk-back) |
LOWER |
guide ~$6.6 vs. cons ~$6.8 (FY2026) |
LOW |
| KKR |
Guide |
Forward monetization pipeline (near-term realized carry) |
BETTER |
guide ~$1.3B vs. prior $1.2B (next-12-mo pipeline) |
MEDIUM |
| KKR |
Guide |
Insurance (Global Atlantic) operating earnings run-rate |
UNKNOWN |
guide ~$300-330M vs. cons ~$310M (quarterly run-rate) |
LOW |
| KKR |
Guide |
Q2 fundraising / inflows |
LOWER |
guide ~$20B vs. cons ~$28B (2026Q2 raise, pre-signaled slowdown) |
MEDIUM |
| KKR |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
MEDIUM |
| KKR |
Return |
5-day cumulative residual |
-3.5% (FOLLOW-THROUGH) |
KKR rallied ~14% off the late-June low (~$89 to ~$101) and +6% in the last week while the S&P was flat, so a low-bar FRE beat is largely priced in — setting up sell-the-news risk. Reported ANI likely only in-line as pre-signaled soft Q2 monetizations and a slower fundraising quarter cap the headline, and a second trim/soft framing of the full-year '$7+' ANI target (now 'below $7') forces out-period estimate cuts. Downward revisions after an in-line print drive continued idiosyncratic weakness (follow-through), only partly cushioned by cheap valuation, aggressive buybacks and insider buying. |
LOW |